Thus, understanding how a reduction in CDC20 appears to favor a melanocytic/proliferative state in melanoma will require substantial further investigation and appears warranted based on our findings for its role in melanoma given that it may alter the ubiquitylation kinetics of the APC/CDC20 complex and many other targets. The gene discussed is CDC20; the disease is melanoma.